PPN20- ESTIMATED RESOURCE USE AND COST OF MITOXANTRONE VS PLACEBO IN PATIENTS WITH PROGRESSIVE-RELAPSING AND SECONDARY-PROGRESSIVE MULTIPLE SCLEROSIS- RESULTS FROM THE MIMS TRIAL

Sep 1, 2001, 00:00
10.1046/j.1524-4733.2001.40202-242.x
https://www.valueinhealthjournal.com/article/S1098-3015(11)71399-7/fulltext
Title : PPN20- ESTIMATED RESOURCE USE AND COST OF MITOXANTRONE VS PLACEBO IN PATIENTS WITH PROGRESSIVE-RELAPSING AND SECONDARY-PROGRESSIVE MULTIPLE SCLEROSIS- RESULTS FROM THE MIMS TRIAL
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)71399-7&doi=10.1046/j.1524-4733.2001.40202-242.x
First page :
Section Title :
Open access? : No
Section Order : 291
Categories :
Tags :
Regions :
ViH Article Tags :